Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England

Addiction

Volumn 112, Issue 8, 2017, Pages 1408-1418

  Marsden, John ^a   Stillwell, Garry ^a   Jones, Hayley ^b   Cooper, Alisha ^c   Eastwood, Brian ^c   Farrell, Michael ^d   Lowden, Tim ^c   Maddalena, Nino ^c   Metcalfe, Chris ^b   Shaw, Jenny ^e   Hickman, Matthew ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

All cause mortality; drug related poisoning mortality; heroin; opioid substitution treatment; opioid use disorder; prison

Indexed keywords

ADULT; COHORT ANALYSIS; DRUG OVERDOSE; ENGLAND; FEMALE; HUMAN; MALE; OPIATE ADDICTION; OPIATE SUBSTITUTION TREATMENT; PRISON; PRISONER; PROSPECTIVE STUDY; RISK FACTOR; RISK REDUCTION; STATISTICS AND NUMERICAL DATA;

ADULT; COHORT STUDIES; DRUG OVERDOSE; ENGLAND; FEMALE; HUMANS; MALE; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PRISONERS; PRISONS; PROSPECTIVE STUDIES; RISK FACTORS; RISK REDUCTION BEHAVIOR;

EID: 85014022485     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.13779     Document Type: Article

References (39)

1. Degenhardt L., Hall W. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet 2012; 379: 55–70.
2. Darke S., Kaye S., Duflou J. Systemic disease among cases of fatal opioid toxicity. Addiction 2006; 101: 1299–1305.
3. Mathers B. M., Degenhardt L., Bucello C., Lemon J., Wiessing L., Hickman M. Mortality among people who inject drugs: a systematic review and meta-analysis. Bull World Health Organ 2013; 91: 102–123.
4. White J. M., Irvine R. J. Mechanisms of fatal opioid overdose. Addiction 1999; 94: 961–972.
5. Calcaterra S., Glanz J., Binswanger I. A. National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999–2009. Drug Alcohol Depend 2013; 131: 263–270.
6. Office for National Statistics. Statistical bulletin: deaths related to drug poisoning in England and Wales: registrations; 2015. Available at: http://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/deathsrelatedtodrugpoisoninginenglandandwales/2015registrations (accessed 30 January 2017) (Archived at http://www.webcitation.org/6ntic0Z90).
7. Fazel S., Bains P., Doll H. Substance abuse and dependence in prisoners: a systematic review. Addiction 2006; 101: 181–191.
8. Farrell M., Marsden J. Acute risk of drug-related death among newly released prisoners in England and Wales. Addiction 2008; 103: 251–255.
9. Merrall E. L., Kariminia A., Binswanger I. A., Hobbs M. S., Farrell M., Marsden J. Meta-analysis of drug-related deaths soon after release from prison. Addiction 2010; 105: 1545–1554.
10. Kinner S. A., Forsyth S., Williams G. Systematic review of record linkage studies of mortality in ex-prisoners: why (good) methods matter. Addiction 2012; 108: 38–49.
11. Hill R., Lyndon A., Withey S., Roberts J., Kershaw Y., MacLachlan J. Ethanol reversal of tolerance to the respiratory depressant effects of morphine. Neuropsychopharmacology 2016; 41: 762–773.
12. McCowan C., Kidd B., Fahey T. Factors associated with mortality in Scottish patients receiving methadone in primary care: retrospective cohort study. BMJ 2009; 338: b2225.
13. Krantz M. J., Rowan S. B., Mehler P. S. Cocaine-related torsade de pointes in a methadone maintenance patient. J Addict Dis 2005; 24: 53–60.
14. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th edn. Arlington, VA: American Psychiatric Publishing; 2013.
15. World Health Organization. International classification of diseases; 2007,10th edn (ICD-10). Available at: http://www.who.int/classifications/apps/icd/icd10online/ (accessed 30 January 2017) (Archived at http://www.webcitation.org/6ntipvNyx).
16. Mattick R. P., Breen C., Kimber J., Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev 2014; Issue 2. Art. No.: CD002207. DOI: 10.1002/14651858.CD002207.pub4.
17. MacArthur G. J., Minozzi S., Martin N., Vickerman P., Deren S., Bruneau J. Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis. BMJ 2012; 345: e5945.
18. Pierce M., Bird S. M., Hickman M., Marsden J., Dunn G., Jones A. Impact of treatment for opioid dependence on fatal drug-related poisoning: a national cohort study in England. Addiction 2016; 111: 298–308.
19. White M., Burton R., Darke S., Eastwood B., Knight J., Millar T. Fatal opioid poisoning: a counterfactual model to estimate the preventive effect of treatment for opioid use disorder in England. Addiction 2015; 110: 1321–1329.
20. Marsden J., Eastwood B., Bradbury C., Dale-Perera A., Farrell M., Hammond P. National Drug Treatment Monitoring System Outcomes Study Group. Effectiveness of community treatments for heroin and crack cocaine addiction in England: a prospective, in-treatment cohort study. Lancet 2009; 374: 1262–1270.
21. Marteau D., Palmer J., Stover H. Introduction of the integrated drug treatment system (IDTS) in English prisons. Int J Prison Health 2010; 6: 117–124.
22. Marsden J., Eastwood B., Bradbury C., Dale-Perera A., Farrell M., Hammond P. Effectiveness of community treatments for heroin and crack cocaine addiction in England: a prospective, during treatment cohort study. Lancet 2009; 374: 1262–1270.
23. Hedrich D., Alves P., Farrell M., Stöver H., Møller L., Mayet S. The effectiveness of opioid maintenance treatment in prison settings: a systematic review. Addiction 2012; 107: 501–517.
24. von Elm E., Altman D. G., Egger M., Pocock S. J., Gøtzsche P. C., Vandenbroucke J. P. STROBE initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007; 370: 1453–1457.
25. National Institute for Health and Care Excellence (NICE). Methadone and buprenorphine for the management of opioid dependence. NICE technology appraisal guidance [TA114]. Available at: https://www.nice.org.uk/guidance/TA114/chapter/About-this-guidance (accessed 30 January 2017) (Archived at http://www.webcitation.org/6ntj6F7gs).
26. Office for National Statistics. Available at: http://www.ons.gov.uk/ons/rel/subnational-health3/deaths-related-to-drug-poisoning/england-and-wales---2013/stb---deaths-related-to-drug-poisoning-in-england-and-wales--2013.html#tab-background-notes (accessed 30 January 2017) (Archived at http://www.webcitation.org/6ntjD3rCb).
27. Davoli M., Bargagli A. M., Perucci C. A., Schifano P., Belleudi V., Hickman M. Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study. Addiction 2007; 102: 1954–1959.
28. Willey H., Eastwood B., Gee I. L., Marsden J. Is treatment for alcohol use disorder associated with reductions in criminal offending? A national data linkage cohort study in England. Drug Alcohol Depend 2016; 161: 67–76.
29. Andersen P. K., Borgan Ø., Gil R. D., Keiding N. Statistical Models Based on Counting Processes. New York: Springer-Verlag; 1993.
30. White I. R., Royston P. Imputing missing covariate values for the cox model. Stat Med 2009; 28: 1982–1998.
31. Little R. J. A., Rubin D. B. Statistical Analysis with Missing Data. New York: Wiley and Sons; 1987.
32. Prentice R. L., Williams B. J., Peterson A. V. On the regression analysis of multivariate failure time data. Biometrika 1981; 68: 373–379.
33. Degenhardt L., Larney S., Kimber J., Gisev N., Farrell M., Dobbins T. The impact of opioid substitution therapy on mortality post-release from prison: retrospective data linkage study. Addiction 2014; 109: 1306–1317.
34. Levesque L. E., Hanley J. A., Kezouh A., Suissa S. Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes. BMJ 2010; 340: b5087.
35. Bird S. M., Fischbacher C. M., Graham L., Fraser A. Impact of opioid substitution therapy for Scotland's prisoners on drug-related deaths soon after prisoner release. Addiction 2015; 110: 1617–1624.
36. Taylor A., Munro A., Allen E., Dunleavy K., Cameron S., Miller L. Low incidence of hepatitis C virus among prisoners in Scotland. Addiction 2013; 108: 1296–1304.
37. Bird S. M., McAuley A., Perry S., Hunter C. Effectiveness of Scotland's National Naloxone Programme for reducing opioid-related deaths: a before (2006–10) versus after (2011–13) comparison. Addiction 2016; 111: 883–891.
38. Lee J. D., McDonald R., Grossman E., McNeely J., Laska E., Rotrosen J. Opioid treatment at release from jail using extended-release naltrexone: a pilot proof-of-concept randomized effectiveness trial. Addiction 2015; 110: 1008–1014.
39. ® (extended-release naltrexone XR-NTX) for prisoners. J Subst Abuse Treat 2015; 59: 52–58.